Gradient Investments’s Bio-Techne TECH Stock Holding History

Gradient Investments’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-18	Closed	-$1.39K	–	1781
2023 Q4	$1.39K	Hold	18	–	–	﹤0.01%	1333
2023 Q3	$1.23K	Hold	18	–	–	﹤0.01%	1311
2023 Q2	$1.47K	Buy	+18	New	+$1.45K	﹤0.01%	1243

Other funds holding TECH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

DDC

DF Dent & Co Baltimore, Maryland $5.27B AUM 7.89% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Gradient Investments's TECH Position: Q1 2024 in Review

Gradient Investments sold out of Bio-Techne (TECH) in Q1 2024, closing a stake of 18 shares — an estimated $1.39K sold.

Gradient Investments first reported a position in TECH in Q2 2023 and held it in 3 quarters. The position peaked at $1.47K in Q2 2023. 557 funds tracked by Wall St. Rank hold TECH as of Q1 2024.

Gradient Investments reported no remaining Bio-Techne position as of Q1 2024 after selling out during the quarter.
Gradient Investments sold 18 Bio-Techne shares in Q1 2024, an estimated $1.39K.
Gradient Investments first reported a position in Bio-Techne in Q2 2023 and held it in 3 quarters.
Gradient Investments's Bio-Techne position peaked at $1.47K in Q2 2023.
557 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2024.

Based on Gradient Investments's 13F filing for Q1 2024, filed 23 Apr 2024.